Targeted protection of hepatocytes from galactosamine toxicity in vivo-Reference-Cited by-同舟云学术

Targeted protection of hepatocytes from galactosamine toxicity in vivo

Published:1990-05 Issue:2 Volume:26 Page:93-96
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Keegan-Rogers Valerie,Wu George Y.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02897251.pdf

Reference31 articles.

1. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41: 99

2. Bertoli D, Segal S (1966) Developmental aspects and some characteristics of mammalian galactose 1-phosphate uridyltransferase. J Biol Chem 241: 4023

3. Chojkier M, Fierer J (1985)d-Galactosamine hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice. Gastroenterology 88: 115

4. Cuatrecasas P, Segal S (1965) Mammalian galactokinase: developmental and adaptive characteristics in the rat liver. J Biol Chem 240: 2382

5. Decker K, Keppler D (1974) Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 71: 77

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomes: An Emerging Approach for the Treatment of Cancer;Current Pharmaceutical Design;2021-08-04

2. Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy;Neurology Research International;2014

3. Methoden der Genübertragung;Grundlagen der Molekularen Medizin;2003

4. Alternative Treatment Approaches to Early Stage or Unresectable Hepatocellular Carcinoma Confined to the Liver;Liver Cancer;1998

5. ASIALOGLYCOPROTEIN/ASIALOGLYCOPROTEIN RECEPTOR (AGP-AGPr) INTERACTION IS AN IMPORTANT MECHANISM FOR THE UPTAKE OF FK506 BY HEPATOCYTES1,2;Transplantation;1997-01